Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients-Reference-Cited by-同舟云学术

Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients

Published:2015-12 Issue:12 Volume:21 Page:2879-2885
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Shelton Edward,Allegretti Jessica R.,Stevens Betsy,Lucci Matthew,Khalili Hamed,Nguyen Deanna D.,Sauk Jenny,Giallourakis Cosmas,Garber John,Hamilton Matthew J.,Tomczak Michal,Makrauer Fredrick,Burakoff Robert B.,Levine Jonathan,de Silva Punyaganie,Friedman Sonia,Ananthakrishnan Ashwin,Korzenik Joshua R.,Yajnik Vijay

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference29 articles.

1. Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

2. Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab

3. Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

4. Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologics in Focus: A Comprehensive Review of Current Biological and Small Molecules Therapies for Crohn’s Disease in the United Arab Emirates (UAE);Gastrointestinal Disorders;2024-07-07

2. Approach to loss of response to advanced therapies in inflammatory bowel disease;World Journal of Gastroenterology;2024-06-14

3. Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial;Clinical Gastroenterology and Hepatology;2024-05

4. Acute interstitial nephritis in patients with inflammatory bowel disease treated with vedolizumab: a systematic review;Scandinavian Journal of Gastroenterology;2024-04-29

5. Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn’s Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study;Advances in Therapy;2024-04-24